204 related articles for article (PubMed ID: 27438608)
1. Benign müllerian glandular inclusions in men undergoing pelvic lymph node dissection.
Gallan AJ; Antic T
Hum Pathol; 2016 Nov; 57():136-139. PubMed ID: 27438608
[TBL] [Abstract][Full Text] [Related]
2. Benign glandular inclusion in obturator lymph node of a man treated for prostate carcinoma.
Moreira Leite KR; Sarkis AS; Camara-Lopes LH
Pathol Int; 2007 Jul; 57(7):454-7. PubMed ID: 17587246
[TBL] [Abstract][Full Text] [Related]
3. Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma.
Corben AD; Nehhozina T; Garg K; Vallejo CE; Brogi E
Am J Surg Pathol; 2010 Aug; 34(8):1211-6. PubMed ID: 20631604
[TBL] [Abstract][Full Text] [Related]
4. Benign glandular inclusions in para-aortic lymph nodes in women undergoing lymphadenectomies.
Schnurr RC; Delgado G; Chun B
Am J Obstet Gynecol; 1978 Apr; 130(7):813-6. PubMed ID: 637105
[TBL] [Abstract][Full Text] [Related]
5. Coexistent Isolated Tumor Cell Clusters of Infiltrating Lobular Carcinoma and Benign Glandular Inclusions of Müllerian (Endosalpingiosis) Type in an Axillary Sentinel Node: Case Report and Review of the Literature.
Groth JV; Prabhu S; Wiley E
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):144-8. PubMed ID: 25203429
[TBL] [Abstract][Full Text] [Related]
6. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
7. [Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature].
Junca A; Frouin E; Irani J; Fromont G; Levillain P
Ann Pathol; 2015 Dec; 35(6):496-501. PubMed ID: 26597142
[TBL] [Abstract][Full Text] [Related]
8. Benign Müllerian inclusions coexisting with breast metastatic carcinoma in an axillary lymph node.
Piana S; Asioli S; Cavazza A
Virchows Arch; 2005 Apr; 446(4):467-9. PubMed ID: 15785927
[No Abstract] [Full Text] [Related]
9. Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis.
Kim HS; Yoon G; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS; Song SY
Int J Clin Exp Pathol; 2015; 8(5):5318-26. PubMed ID: 26191233
[TBL] [Abstract][Full Text] [Related]
10. Endocervicosis involving axillary lymph nodes: first case report.
Mukonoweshuro P; McCluggage WG
Int J Gynecol Pathol; 2014 Nov; 33(6):620-3. PubMed ID: 25272302
[TBL] [Abstract][Full Text] [Related]
11. Endosalpingiosis Is Negative for GATA3.
White MJ; Vang R; Argani P; Cimino-Mathews A
Arch Pathol Lab Med; 2021 Nov; 145(11):1448-1452. PubMed ID: 33571371
[TBL] [Abstract][Full Text] [Related]
12. Re: Alberto Briganti, Umberto Capitanio, Felix K.-H. Chun, et al. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. Eur Urol 2008;54:794-804.
Cai T; Nesi G; Bartoletti R
Eur Urol; 2009 Feb; 55(2):e32-3; author reply e34-5. PubMed ID: 18760527
[No Abstract] [Full Text] [Related]
13. Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival.
Bostwick DG; Qian J; Pacelli A; Zincke H; Blute M; Bergstralh EJ; Slezak JM; Cheng L
J Urol; 2002 Sep; 168(3):1204-11. PubMed ID: 12187268
[TBL] [Abstract][Full Text] [Related]
14. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
Hruby S; Englberger C; Lusuardi L; Schätz T; Kunit T; Abdel-Aal AM; Hager M; Janetschek G
J Urol; 2015 Aug; 194(2):357-63. PubMed ID: 25896557
[TBL] [Abstract][Full Text] [Related]
17. Endosalpingiosis in axillary lymph nodes simulating metastatic breast carcinoma: a potential diagnostic pitfall.
Salehi AH; Omeroglu G; Kanber Y; Omeroglu A
Int J Surg Pathol; 2013 Dec; 21(6):610-2. PubMed ID: 24021901
[TBL] [Abstract][Full Text] [Related]
18. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
Abdollah F; Sun M; Thuret R; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Int J Urol; 2012 Jul; 19(7):645-51. PubMed ID: 22416788
[TBL] [Abstract][Full Text] [Related]
19. Benign müllerian inclusions in pelvic and paraaortic lymph nodes.
Reich O; Tamussino K; Haas J; Winter R
Gynecol Oncol; 2000 Aug; 78(2):242-4. PubMed ID: 10926810
[TBL] [Abstract][Full Text] [Related]
20. Axillary Lymph Node Inclusions.
Cimino-Mathews A
Surg Pathol Clin; 2018 Mar; 11(1):43-59. PubMed ID: 29413659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
